SMN-knockdown in NSC34 cells demonstrated its efficient down-regulation similar to levels observed in primary fibroblasts derived from type-1 SMA patients ([36], Fig. 3B). The gene discussed is SMN2; the disease is spinal muscular atrophy, type 1.